United States Temozolomide Market Report 2016

November 2016 | 109 pages | ID: U3EEDD583FBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Temozolomide

Revenue, means the sales value of Temozolomide

This report studies sales (consumption) of Temozolomide in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Merck & Co., Inc.
• Tianjin Tasly Pharmaceutical Co.,Ltd
• Miracalus
• Sun
• Macleods
• BMW
• Cipla
• Ind- Swift
• Panacea
• Fulford
• Celon
• Natco
• Lunarsun
• LUMMY
• Jianyuan

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Product in Semi Regulated Markets
• Product in Regulated Markets
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Temozolomide in each application, can be divided into

• Nitrosourea- and procarbazine-refractory anaplastic astrocytoma
• Newly diagnosed glioblastoma multiforme
• Application 3

Contents

United States Temozolomide Market Report 2016

1 TEMOZOLOMIDE OVERVIEW

1.1 Product Overview and Scope of Temozolomide
1.2 Classification of Temozolomide
  1.2.1 Product in Semi Regulated Markets
  1.2.2 Product in Regulated Markets
  1.2.3 Type III
1.3 Application of Temozolomide
  1.3.1 Nitrosourea- and procarbazine-refractory anaplastic astrocytoma
  1.3.2 Newly diagnosed glioblastoma multiforme
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Temozolomide (2011-2021)
  1.4.1 United States Temozolomide Sales and Growth Rate (2011-2021)
  1.4.2 United States Temozolomide Revenue and Growth Rate (2011-2021)

2 UNITED STATES TEMOZOLOMIDE COMPETITION BY MANUFACTURERS

2.1 United States Temozolomide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Temozolomide Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Temozolomide Average Price by Manufactures (2015 and 2016)
2.4 Temozolomide Market Competitive Situation and Trends
  2.4.1 Temozolomide Market Concentration Rate
  2.4.2 Temozolomide Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TEMOZOLOMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Temozolomide Sales and Market Share by Type (2011-2016)
3.2 United States Temozolomide Revenue and Market Share by Type (2011-2016)
3.3 United States Temozolomide Price by Type (2011-2016)
3.4 United States Temozolomide Sales Growth Rate by Type (2011-2016)

4 UNITED STATES TEMOZOLOMIDE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Temozolomide Sales and Market Share by Application (2011-2016)
4.2 United States Temozolomide Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES TEMOZOLOMIDE MANUFACTURERS PROFILES/ANALYSIS

5.1 Merck & Co., Inc.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Temozolomide Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Merck & Co., Inc. Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Tianjin Tasly Pharmaceutical Co.,Ltd
  5.2.2 Temozolomide Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Miracalus
  5.3.2 Temozolomide Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Miracalus Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sun
  5.4.2 Temozolomide Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Macleods
  5.5.2 Temozolomide Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Macleods Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 BMW
  5.6.2 Temozolomide Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 BMW Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Cipla
  5.7.2 Temozolomide Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Cipla Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Ind- Swift
  5.8.2 Temozolomide Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Ind- Swift Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Panacea
  5.9.2 Temozolomide Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Panacea Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Fulford
  5.10.2 Temozolomide Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Fulford Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Celon
5.12 Natco
5.13 Lunarsun
5.14 LUMMY
5.15 Jianyuan

6 TEMOZOLOMIDE MANUFACTURING COST ANALYSIS

6.1 Temozolomide Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Temozolomide

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Temozolomide Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Temozolomide Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES TEMOZOLOMIDE MARKET FORECAST (2016-2021)

10.1 United States Temozolomide Sales, Revenue Forecast (2016-2021)
10.2 United States Temozolomide Sales Forecast by Type (2016-2021)
10.3 United States Temozolomide Sales Forecast by Application (2016-2021)
10.4 Temozolomide Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Temozolomide
Table Classification of Temozolomide
Figure United States Sales Market Share of Temozolomide by Type in 2015
Figure Product in Semi Regulated Markets Picture
Figure Product in Regulated Markets Picture
Table Application of Temozolomide
Figure United States Sales Market Share of Temozolomide by Application in 2015
Figure Nitrosourea- and procarbazine-refractory anaplastic astrocytoma Examples
Figure Newly diagnosed glioblastoma multiforme Examples
Figure United States Temozolomide Sales and Growth Rate (2011-2021)
Figure United States Temozolomide Revenue and Growth Rate (2011-2021)
Table United States Temozolomide Sales of Key Manufacturers (2015 and 2016)
Table United States Temozolomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Temozolomide Sales Share by Manufacturers
Figure 2016 Temozolomide Sales Share by Manufacturers
Table United States Temozolomide Revenue by Manufacturers (2015 and 2016)
Table United States Temozolomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Temozolomide Revenue Share by Manufacturers
Table 2016 United States Temozolomide Revenue Share by Manufacturers
Table United States Market Temozolomide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Temozolomide Average Price of Key Manufacturers in 2015
Figure Temozolomide Market Share of Top 3 Manufacturers
Figure Temozolomide Market Share of Top 5 Manufacturers
Table United States Temozolomide Sales by Type (2011-2016)
Table United States Temozolomide Sales Share by Type (2011-2016)
Figure United States Temozolomide Sales Market Share by Type in 2015
Table United States Temozolomide Revenue and Market Share by Type (2011-2016)
Table United States Temozolomide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Temozolomide by Type (2011-2016)
Table United States Temozolomide Price by Type (2011-2016)
Figure United States Temozolomide Sales Growth Rate by Type (2011-2016)
Table United States Temozolomide Sales by Application (2011-2016)
Table United States Temozolomide Sales Market Share by Application (2011-2016)
Figure United States Temozolomide Sales Market Share by Application in 2015
Table United States Temozolomide Sales Growth Rate by Application (2011-2016)
Figure United States Temozolomide Sales Growth Rate by Application (2011-2016)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Temozolomide Sales Market Share (2011-2016)
Table Tianjin Tasly Pharmaceutical Co.,Ltd Basic Information List
Table Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Sales Market Share (2011-2016)
Table Miracalus Basic Information List
Table Miracalus Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Miracalus Temozolomide Sales Market Share (2011-2016)
Table Sun Basic Information List
Table Sun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Temozolomide Sales Market Share (2011-2016)
Table Macleods Basic Information List
Table Macleods Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Macleods Temozolomide Sales Market Share (2011-2016)
Table BMW Basic Information List
Table BMW Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMW Temozolomide Sales Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Temozolomide Sales Market Share (2011-2016)
Table Ind- Swift Basic Information List
Table Ind- Swift Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ind- Swift Temozolomide Sales Market Share (2011-2016)
Table Panacea Basic Information List
Table Panacea Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Panacea Temozolomide Sales Market Share (2011-2016)
Table Fulford Basic Information List
Table Fulford Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fulford Temozolomide Sales Market Share (2011-2016)
Table Celon Basic Information List
Table Celon Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celon Temozolomide Sales Market Share (2011-2016)
Table Natco Basic Information List
Table Natco Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Natco Temozolomide Sales Market Share (2011-2016)
Table Lunarsun Basic Information List
Table Lunarsun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lunarsun Temozolomide Sales Market Share (2011-2016)
Table LUMMY Basic Information List
Table LUMMY Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table LUMMY Temozolomide Sales Market Share (2011-2016)
Table Jianyuan Basic Information List
Table Jianyuan Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jianyuan Temozolomide Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Temozolomide
Figure Manufacturing Process Analysis of Temozolomide
Figure Temozolomide Industrial Chain Analysis
Table Raw Materials Sources of Temozolomide Major Manufacturers in 2015
Table Major Buyers of Temozolomide
Table Distributors/Traders List
Figure United States Temozolomide Production and Growth Rate Forecast (2016-2021)
Figure United States Temozolomide Revenue and Growth Rate Forecast (2016-2021)
Table United States Temozolomide Production Forecast by Type (2016-2021)
Table United States Temozolomide Consumption Forecast by Application (2016-2021)